Skip to main content
Top
Published in: BMC Nephrology 1/2017

Open Access 01-12-2017 | Research article

Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers

Authors: Harald Seeger, Andrea Kaelin, Pietro M. Ferraro, Damian Weber, Philippe Jaeger, Patrice Ambuehl, William G. Robertson, Robert Unwin, Carsten A. Wagner, Nilufar Mohebbi

Published in: BMC Nephrology | Issue 1/2017

Login to get access

Abstract

Background

Kidney stone disease is common in industrialized countries. Recently, it has attracted growing attention, because of its significant association with adverse renal outcomes, including end stage renal disease. Calcium-containing kidney stones are frequent with high recurrence rates. While hypercalciuria is a well-known risk factor, restricted intake of animal protein and sodium, combined with normal dietary calcium, has been shown to be more effective in stone prevention compared with a low-calcium diet. Notably, the average sodium intake in Switzerland is twice as high as the WHO recommendation, while the intake of milk and dairy products is low.

Methods

We retrospectively analyzed Swiss recurrent kidney stone formers (rKSF) to test the impact of a low-sodium in combination with a low-calcium diet on the urinary risk profile. In patients with recurrent calcium oxalate containing stones, we investigated both, the consequence of a low-sodium diet on urinary volume and calcium excretion, and the influence of a low-sodium low-calcium diet on urinary oxalate excretion.

Results

Of the 169 patients with CaOx stones, 49 presented with hypercalciuria at baseline. The diet resulted in a highly significant reduction in 24-h urinary sodium and calcium excretion: from 201 ± 89 at baseline to 128 ± 88 mmol/d for sodium (p < 0.0001), and from 5.67 ± 3.01 to 4.06 ± 2.46 mmol/d (p < 0.0001) for calcium, respectively. Urine volume remained unchanged. Notably, no increase in oxalate excretion occurred on the restricted diet (0.39 ± 0.26 vs 0.39 ± 0.19 mmol/d, p = 0.277). Calculated Psf (probability of stone formation) values were only predictive for the risk of calcium phosphate stones.

Conclusion

A diet low in sodium and calcium in recurrent calcium oxalate stone formers resulted in a significant reduction of urinary calcium excretion, but no change in urine volume. In this population with apparently low intake of dairy products, calcium restriction does not necessarily result in increased urinary oxalate excretion. However, based on previous studies, we recommend a normal dietary calcium intake to avoid a potential increase in urinary oxalate excretion and unfavorable effects on bone metabolism in hypercalciuric KSFs.
Appendix
Available only for authorised users
Literature
2.
go back to reference Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96.PubMedCentralPubMed Romero V, Akpinar H, Assimos DG. Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010;12(2–3):e86–96.PubMedCentralPubMed
3.
go back to reference Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract. 2010;116(3):c159–71.CrossRefPubMed Johri N, Cooper B, Robertson W, Choong S, Rickards D, Unwin R. An update and practical guide to renal stone management. Nephron Clin Pract. 2010;116(3):c159–71.CrossRefPubMed
4.
go back to reference Vupputuri S, Soucie JM, McClellan W, Sandler DP. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol. 2004;14(3):222–8.CrossRefPubMed Vupputuri S, Soucie JM, McClellan W, Sandler DP. History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol. 2004;14(3):222–8.CrossRefPubMed
5.
go back to reference Shoag J, Halpern J, Goldfarb DS, Eisner BH. Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol. 2014;192(5):1440–5.CrossRefPubMed Shoag J, Halpern J, Goldfarb DS, Eisner BH. Risk of chronic and end stage kidney disease in patients with nephrolithiasis. J Urol. 2014;192(5):1440–5.CrossRefPubMed
6.
go back to reference Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):804–11.CrossRefPubMedCentralPubMed Rule AD, Bergstralh EJ, Melton LJ 3rd, Li X, Weaver AL, Lieske JC. Kidney stones and the risk for chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(4):804–11.CrossRefPubMedCentralPubMed
7.
go back to reference El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012;7(9):1409–15.CrossRefPubMedCentralPubMed El-Zoghby ZM, Lieske JC, Foley RN, Bergstralh EJ, Li X, Melton LJ 3rd, Krambeck AE, Rule AD. Urolithiasis and the risk of ESRD. Clin J Am Soc Nephrol. 2012;7(9):1409–15.CrossRefPubMedCentralPubMed
9.
go back to reference Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310(4):408–15.CrossRefPubMedCentralPubMed Ferraro PM, Taylor EN, Eisner BH, Gambaro G, Rimm EB, Mukamal KJ, Curhan GC. History of kidney stones and the risk of coronary heart disease. JAMA. 2013;310(4):408–15.CrossRefPubMedCentralPubMed
10.
go back to reference Meneses JA, Lucas FM, Assuncao FC, Castro JP, Monteiro RB. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res. 2012;40(3):225–9.CrossRefPubMed Meneses JA, Lucas FM, Assuncao FC, Castro JP, Monteiro RB. The impact of metaphylaxis of kidney stone disease in the renal function at long term in active kidney stone formers patients. Urol Res. 2012;40(3):225–9.CrossRefPubMed
11.
go back to reference Robertson WG. Is prevention of stone recurrence financially worthwhile? Urol Res. 2006;34(2):157–61.CrossRefPubMed Robertson WG. Is prevention of stone recurrence financially worthwhile? Urol Res. 2006;34(2):157–61.CrossRefPubMed
12.
go back to reference Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.CrossRefPubMed Borghi L, Schianchi T, Meschi T, Guerra A, Allegri F, Maggiore U, Novarini A. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med. 2002;346(2):77–84.CrossRefPubMed
13.
go back to reference Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T. Salt and nephrolithiasis. Nephrol Dial Transplant. 2016;31(1):39–45.CrossRefPubMed Ticinesi A, Nouvenne A, Maalouf NM, Borghi L, Meschi T. Salt and nephrolithiasis. Nephrol Dial Transplant. 2016;31(1):39–45.CrossRefPubMed
14.
go back to reference He FJ, Markandu ND, Sagnella GA, MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension (Dallas, Tex : 1979). 2001;38(3):317–20.CrossRef He FJ, Markandu ND, Sagnella GA, MacGregor GA. Effect of salt intake on renal excretion of water in humans. Hypertension (Dallas, Tex : 1979). 2001;38(3):317–20.CrossRef
15.
go back to reference Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol. 2009;181(3):1140–4.CrossRefPubMed Stoller ML, Chi T, Eisner BH, Shami G, Gentle DL. Changes in urinary stone risk factors in hypocitraturic calcium oxalate stone formers treated with dietary sodium supplementation. J Urol. 2009;181(3):1140–4.CrossRefPubMed
16.
go back to reference Schoen T, Blum J, Paccaud F, Burnier M, Bochud M, Conen D. Factors associated with 24-hour urinary volume: the Swiss salt survey. BMC Nephrol. 2013;14:246.CrossRefPubMedCentralPubMed Schoen T, Blum J, Paccaud F, Burnier M, Bochud M, Conen D. Factors associated with 24-hour urinary volume: the Swiss salt survey. BMC Nephrol. 2013;14:246.CrossRefPubMedCentralPubMed
18.
go back to reference Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB. Risk factors in calcium stone disease of the urinary tract. Br J Urol. 1978;50(7):449–54.CrossRefPubMed Robertson WG, Peacock M, Heyburn PJ, Marshall DH, Clark PB. Risk factors in calcium stone disease of the urinary tract. Br J Urol. 1978;50(7):449–54.CrossRefPubMed
19.
go back to reference Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med. 1953;46(12):1077–81.PubMedCentralPubMed Albright F, Henneman P, Benedict PH, Forbes AP. Idiopathic hypercalciuria: a preliminary report. Proc R Soc Med. 1953;46(12):1077–81.PubMedCentralPubMed
20.
go back to reference Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141–52.CrossRefPubMed Coe FL, Parks JH, Asplin JR. The pathogenesis and treatment of kidney stones. N Engl J Med. 1992;327(16):1141–52.CrossRefPubMed
22.
go back to reference Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007;292(1):F66–75.CrossRefPubMed Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007;292(1):F66–75.CrossRefPubMed
23.
go back to reference Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016;12(9):519–33. Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016;12(9):519–33.
24.
go back to reference Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73(4):489–96.CrossRefPubMed Curhan GC, Taylor EN. 24-h uric acid excretion and the risk of kidney stones. Kidney Int. 2008;73(4):489–96.CrossRefPubMed
25.
go back to reference Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.CrossRefPubMed Borghi L, Meschi T, Amato F, Briganti A, Novarini A, Giannini A. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol. 1996;155(3):839–43.CrossRefPubMed
26.
go back to reference Phillips MJ, Cooke JN. Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet. 1967;1(7504):1354–7.CrossRefPubMed Phillips MJ, Cooke JN. Relation between urinary calcium and sodium in patients with idiopathic hypercalciuria. Lancet. 1967;1(7504):1354–7.CrossRefPubMed
27.
go back to reference Silver J, Rubinger D, Friedlaender MM, Popovtzer MM. Sodium-dependent idiopathic hypercalciuria in renal-stone formers. Lancet. 1983;2(8348):484–6.CrossRefPubMed Silver J, Rubinger D, Friedlaender MM, Popovtzer MM. Sodium-dependent idiopathic hypercalciuria in renal-stone formers. Lancet. 1983;2(8348):484–6.CrossRefPubMed
28.
go back to reference Nascimento L, Oliveros FH, Cunningham E. Renal handling of sodium and calcium in hypercalciuria. Clin Pharmacol Ther. 1984;35(3):342–7.CrossRefPubMed Nascimento L, Oliveros FH, Cunningham E. Renal handling of sodium and calcium in hypercalciuria. Clin Pharmacol Ther. 1984;35(3):342–7.CrossRefPubMed
29.
go back to reference Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982;22(3):292–6.CrossRefPubMed Muldowney FP, Freaney R, Moloney MF. Importance of dietary sodium in the hypercalciuria syndrome. Kidney Int. 1982;22(3):292–6.CrossRefPubMed
30.
go back to reference Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010;91(3):565–70.CrossRefPubMed Nouvenne A, Meschi T, Prati B, Guerra A, Allegri F, Vezzoli G, Soldati L, Gambaro G, Maggiore U, Borghi L. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: a 3-mo randomized controlled trial. Am J Clin Nutr. 2010;91(3):565–70.CrossRefPubMed
31.
go back to reference Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994;60(3):424–9.PubMed Burtis WJ, Gay L, Insogna KL, Ellison A, Broadus AE. Dietary hypercalciuria in patients with calcium oxalate kidney stones. Am J Clin Nutr. 1994;60(3):424–9.PubMed
32.
go back to reference Bleich HL, Moore MJ, Lemann J Jr, Adams ND, Gray RW. Urinary calcium excretion in human beings. N Engl J Med. 1979;301(10):535–41.CrossRefPubMed Bleich HL, Moore MJ, Lemann J Jr, Adams ND, Gray RW. Urinary calcium excretion in human beings. N Engl J Med. 1979;301(10):535–41.CrossRefPubMed
34.
go back to reference Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18(7):2198–204.CrossRefPubMed Taylor EN, Curhan GC. Oxalate intake and the risk for nephrolithiasis. J Am Soc Nephrol. 2007;18(7):2198–204.CrossRefPubMed
35.
go back to reference Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation. Urol Res. 2004;32(5):311–6.CrossRefPubMed Holmes RP, Assimos DG. The impact of dietary oxalate on kidney stone formation. Urol Res. 2004;32(5):311–6.CrossRefPubMed
36.
go back to reference Chai W, Liebman M. Assessment of oxalate absorption from almonds and black beans with and without the use of an extrinsic label. J Urol. 2004;172(3):953–7.CrossRefPubMed Chai W, Liebman M. Assessment of oxalate absorption from almonds and black beans with and without the use of an extrinsic label. J Urol. 2004;172(3):953–7.CrossRefPubMed
37.
go back to reference Marshall RW, Cochran M, Hodgkinson A. Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci. 1972;43(1):91–9.CrossRefPubMed Marshall RW, Cochran M, Hodgkinson A. Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci. 1972;43(1):91–9.CrossRefPubMed
38.
go back to reference Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833–8.CrossRefPubMed Curhan GC, Willett WC, Rimm EB, Stampfer MJ. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med. 1993;328(12):833–8.CrossRefPubMed
39.
go back to reference Zarembski PM, Hodgkinson A. Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta. 1969;25(1):1–10.CrossRefPubMed Zarembski PM, Hodgkinson A. Some factors influencing the urinary excretion of oxalic acid in man. Clin Chim Acta. 1969;25(1):1–10.CrossRefPubMed
40.
go back to reference Nakada T, Sasagawa I, Furuta H, Katayama T, Shimazaki J. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol. 1988;15(3–4):264–70.CrossRefPubMed Nakada T, Sasagawa I, Furuta H, Katayama T, Shimazaki J. Effect of high-calcium diet on urinary oxalate excretion in urinary stone formers. Eur Urol. 1988;15(3–4):264–70.CrossRefPubMed
41.
go back to reference Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29(6):715–34.CrossRefPubMedCentralPubMed Gambaro G, Croppi E, Coe F, Lingeman J, Moe O, Worcester E, Buchholz N, Bushinsky D, Curhan GC, Ferraro PM, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: a consensus statement. J Nephrol. 2016;29(6):715–34.CrossRefPubMedCentralPubMed
42.
go back to reference Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59(1):270–6.CrossRefPubMed Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int. 2001;59(1):270–6.CrossRefPubMed
43.
go back to reference Holmes RP, Ambrosius WT, Assimos DG. Dietary oxalate loads and renal oxalate handling. J Urol. 2005;174(3):943–7. discussion 947CrossRefPubMed Holmes RP, Ambrosius WT, Assimos DG. Dietary oxalate loads and renal oxalate handling. J Urol. 2005;174(3):943–7. discussion 947CrossRefPubMed
44.
go back to reference von Unruh GE, Voss S, Sauerbruch T, Hesse A. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004;15(6):1567–73.CrossRefPubMed von Unruh GE, Voss S, Sauerbruch T, Hesse A. Dependence of oxalate absorption on the daily calcium intake. J Am Soc Nephrol. 2004;15(6):1567–73.CrossRefPubMed
Metadata
Title
Changes in urinary risk profile after short-term low sodium and low calcium diet in recurrent Swiss kidney stone formers
Authors
Harald Seeger
Andrea Kaelin
Pietro M. Ferraro
Damian Weber
Philippe Jaeger
Patrice Ambuehl
William G. Robertson
Robert Unwin
Carsten A. Wagner
Nilufar Mohebbi
Publication date
01-12-2017
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2017
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-017-0755-7

Other articles of this Issue 1/2017

BMC Nephrology 1/2017 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.